FDA DrugClass IINotable

FDA Recall: Bortezomib for Injection 3.5mg/Vial, 10 mL per Single-Dose Vial, For Intravenous or Subcutaneous Use

Date: 2026-07-15
Brand: Reliance Life Sciences Private Limited
Category: Drug
FDA Class: Class II

Description

Lack of Sterility Assurance

Hazard

Lack of Sterility Assurance

Remedy

11,400 vials

Related Recalls